These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 17291836)

  • 1. Glucocorticoids as an adjuvant treatment to intravenous antibiotics for cystic fibrosis pulmonary exacerbations: a UK Survey.
    Hester KL; Powell T; Downey DG; Elborn JS; Jarad NA
    J Cyst Fibros; 2007 Jul; 6(4):311-3. PubMed ID: 17291836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study design considerations for the Standardized Treatment of Pulmonary Exacerbations 2 (STOP2): A trial to compare intravenous antibiotic treatment durations in CF.
    Heltshe SL; West NE; VanDevanter DR; Sanders DB; Beckett VV; Flume PA; Goss CH;
    Contemp Clin Trials; 2018 Jan; 64():35-40. PubMed ID: 29170074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolongation of antibiotic treatment for cystic fibrosis pulmonary exacerbations.
    Waters V; Stanojevic S; Klingel M; Chiang J; Sonneveld N; Kukkar R; Tullis E; Ratjen F
    J Cyst Fibros; 2015 Nov; 14(6):770-6. PubMed ID: 26265220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic use in cystic fibrosis.
    Eisenberg JD
    Curr Opin Pulm Med; 1996 Nov; 2(6):439-46. PubMed ID: 9363182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extending the course of intravenous antibiotics in adult patients with cystic fibrosis with acute pulmonary exacerbations.
    Sequeiros IM; Jarad NA
    Chron Respir Dis; 2012; 9(4):213-20. PubMed ID: 22637747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multiresistant bacteria: a randomised, double-blind, controlled clinical trial.
    Aaron SD; Vandemheen KL; Ferris W; Fergusson D; Tullis E; Haase D; Berthiaume Y; Brown N; Wilcox P; Yozghatlian V; Bye P; Bell S; Chan F; Rose B; Jeanneret A; Stephenson A; Noseworthy M; Freitag A; Paterson N; Doucette S; Harbour C; Ruel M; MacDonald N
    Lancet; 2005 Aug 6-12; 366(9484):463-71. PubMed ID: 16084254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of acute antibiotic therapy on the pulmonary exacerbation endpoint in cystic fibrosis clinical trials.
    Mayer-Hamblett N; Saiman L; Lands LC; Anstead M; Rosenfeld M; Kloster M; Fisher L; Ratjen F
    Contemp Clin Trials; 2013 Sep; 36(1):99-105. PubMed ID: 23770109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nebulized tobramycin in the treatment of adult CF pulmonary exacerbations.
    Al-Aloul M; Nazareth D; Walshaw M
    J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27(4):299-305. PubMed ID: 24219814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous antibiotics for pulmonary exacerbations in people with cystic fibrosis.
    Hurley MN; ; Prayle AP; Flume P
    Paediatr Respir Rev; 2015 Sep; 16(4):246-8. PubMed ID: 26298057
    [No Abstract]   [Full Text] [Related]  

  • 10. Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis.
    de Boer K; Vandemheen KL; Tullis E; Doucette S; Fergusson D; Freitag A; Paterson N; Jackson M; Lougheed MD; Kumar V; Aaron SD
    Thorax; 2011 Aug; 66(8):680-5. PubMed ID: 21680566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A survey of extended-interval aminoglycoside dosing practices in United States adult cystic fibrosis programs.
    Prescott WA
    Respir Care; 2014 Sep; 59(9):1353-9. PubMed ID: 24782555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: VI. Executive summary.
    Zobell JT; Young DC; Waters CD; Ampofo K; Stockmann C; Sherwin CM; Spigarelli MG
    Pediatr Pulmonol; 2013 Jun; 48(6):525-37. PubMed ID: 23359557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ciprofloxacin versus tobramycin plus azlocillin in pulmonary exacerbations in adult patients with cystic fibrosis.
    Bosso JA; Black PG; Matsen JM
    Am J Med; 1987 Apr; 82(4A):180-4. PubMed ID: 3555033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of pulmonary exacerbations in patients with cystic fibrosis infected with multi-resistant bacteria.
    Block JK; Vandemheen KL; Tullis E; Fergusson D; Doucette S; Haase D; Berthiaume Y; Brown N; Wilcox P; Bye P; Bell S; Noseworthy M; Pedder L; Freitag A; Paterson N; Aaron SD
    Thorax; 2006 Nov; 61(11):969-74. PubMed ID: 16844728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of anti-inflammatory medications in cystic fibrosis: trends and physician attitudes.
    Oermann CM; Sockrider MM; Konstan MW
    Chest; 1999 Apr; 115(4):1053-8. PubMed ID: 10208207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary Exacerbations in Children with Cystic Fibrosis.
    Waters V; Ratjen F
    Ann Am Thorac Soc; 2015 Nov; 12 Suppl 2():S200-6. PubMed ID: 26595740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic therapy for pulmonary exacerbations in adults with cystic fibrosis.
    Elpern EH; Patel G; Balk RA
    Medsurg Nurs; 2007 Oct; 16(5):293-8; quiz 299. PubMed ID: 18072667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of hospital and home intravenous antibiotic therapy in adults with cystic fibrosis.
    Esmond G; Butler M; McCormack AM
    J Clin Nurs; 2006 Jan; 15(1):52-60. PubMed ID: 16390524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous antibiotics reduce the presence of Aspergillus in adult cystic fibrosis sputum.
    Baxter CG; Rautemaa R; Jones AM; Webb AK; Bull M; Mahenthiralingam E; Denning DW
    Thorax; 2013 Jul; 68(7):652-7. PubMed ID: 23513028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infection with Burkholderia cepacia complex bacteria and pulmonary exacerbations of cystic fibrosis.
    St Denis M; Ramotar K; Vandemheen K; Tullis E; Ferris W; Chan F; Lee C; Slinger R; Aaron SD
    Chest; 2007 Apr; 131(4):1188-96. PubMed ID: 17426227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.